Discounted Cash Flow (DCF) Analysis Unlevered

IRadimed Corporation (IRMD)

$30.06

-0.03 (-0.10%)
All numbers are in Millions, Currency in USD
Stock DCF: - | 30.06 | undervalue

Operating Data

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue 23.0830.4438.5231.7241.8149.4058.3768.9681.4896.27
Revenue (%)
EBITDA 2.717.3010.290.7211.249.0510.6912.6314.9217.63
EBITDA (%)
EBIT 1.406.209.04-0.629.847.068.349.8611.6513.76
EBIT (%)
Depreciation 1.311.111.241.341.411.992.352.773.283.87
Depreciation (%)

Balance Sheet Data

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 26.3434.3846.2551.9862.5065.2677.1191.10107.63127.17
Total Cash (%)
Account Receivables 3.784.217.294.575.147.498.8510.4612.3614.60
Account Receivables (%)
Inventories 4.214.063.643.934.306.307.448.7910.3812.27
Inventories (%)
Accounts Payable 0.660.770.990.660.781.181.391.641.942.29
Accounts Payable (%)
Capital Expenditure -0.82-0.26-0.49-0.64-0.74-0.94-1.11-1.31-1.55-1.83
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 30.06
Beta 1.060
Diluted Shares Outstanding 12.44
Cost of Debt
Tax Rate 5.19
After-tax Cost of Debt -%
Risk-Free Rate
Market Risk Premium
Cost of Equity 8.809
Total Debt 2.48
Total Equity 373.95
Total Capital 376.43
Debt Weighting 0.66
Equity Weighting 99.34
Wacc

Build Up Free Cash

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue 23.0830.4438.5231.7241.8149.4058.3768.9681.4896.27
EBITDA 2.717.3010.290.7211.249.0510.6912.6314.9217.63
EBIT 1.406.209.04-0.629.847.068.349.8611.6513.76
Tax Rate 64.21%-1.71%-6.50%321.92%5.19%76.62%76.62%76.62%76.62%76.62%
EBIAT 0.506.309.631.379.331.651.952.302.723.22
Depreciation 1.311.111.241.341.411.992.352.773.283.87
Accounts Receivable --0.43-3.082.72-0.56-2.36-1.36-1.61-1.90-2.24
Inventories -0.150.42-0.29-0.37-2-1.14-1.35-1.60-1.88
Accounts Payable -0.120.22-0.340.130.390.210.250.300.35
Capital Expenditure -0.82-0.26-0.49-0.64-0.74-0.94-1.11-1.31-1.55-1.83
UFCF 0.986.987.944.169.19-1.260.901.071.261.49
WACC
PV UFCF -----
SUM PV UFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) -
Free cash flow (t + 1) 1.52
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -59.52
Equity Value -
Shares Outstanding 12.44
Equity Value Per Share -